UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Exercise and Nutrition Interventions During Chemotherapy K07
Phase 2
Recruiting
- Conditions
- Neuropathy;Peripheral
- Interventions
- Behavioral: EXCAP ExerciseBehavioral: Nutrition Education
- First Posted Date
- 2019-02-28
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 80
- Registration Number
- NCT03858153
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
Denosumab for Smoldering Multiple Myeloma
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 20
- Registration Number
- NCT03839459
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Promotion of Successful Parenting
Not Applicable
Completed
- Conditions
- Pregnant and Parenting Women
- Interventions
- Behavioral: Child-Parent Psychotherapy (CPP)Behavioral: Community Health Worker (CHW) home visitation
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 222
- Registration Number
- NCT03808987
- Locations
- 🇺🇸
Mt. Hope Family Center, Rochester, New York, United States
Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- University of Rochester
- Registration Number
- NCT03796507
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Phase 2
Active, not recruiting
- Conditions
- Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
- Interventions
- First Posted Date
- 2018-12-27
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 39
- Registration Number
- NCT03788291
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
Phase 2
Active, not recruiting
- Conditions
- Advanced Rectal Cancer
- Interventions
- Drug: FOLFOX
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 12
- Registration Number
- NCT03781323
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸University of Rochester, James P. Wilmot Cancer Center, Rochester, New York, United States
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Early Phase 1
Completed
- Conditions
- Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
- Interventions
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 33
- Registration Number
- NCT03771157
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Talk Therapy by Phone to Promote Treatment for Alcohol Problems
Not Applicable
Completed
- Conditions
- Alcohol Use DisorderAlcohol Abuse
- Interventions
- Behavioral: CBT by Phone to Promote TreatmentOther: Reading the Subject a Pamphlet on Obtaining Alcohol Use Disorder Treatment
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 400
- Registration Number
- NCT03758274
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
Phase 2
Recruiting
- Conditions
- DLBCL
- Interventions
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 40
- Registration Number
- NCT03758989
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Residential Cleaning of Indoor Air to Protect COPD Patients
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Device: HEPAirX air filterDevice: control air filter
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 9
- Registration Number
- NCT03750292
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath